Long-term proarrhythmic pharmacotherapy among patients with congenital long QT syndrome and risk of arrhythmia and mortality.

Weeke, Peter E; Kellemann, Jesper S; Jespersen, Camilla Bang; Theilade, Juliane; Kanters, Jørgen K; Hansen, Michael Skov; Christiansen, Michael; Marstrand, Peter; Gislason, Gunnar H; Torp-Pedersen, Christian; Bundgaard, Henning; Jensen, Henrik K; Tfelt-Hansen, Jacob.
Eur Heart J; 2019 May 11.
Artigo em Inglês | MEDLINE | ID: mdl-31079148

Não foram localizados documentos relacionados